-
Scaling up key as French firm bets on sterile mosquitoes
-
Myanmar's president meets China's Xi in Beijing: state media
-
'The mullahs' team': Split loyalties for Iran fans at World Cup
-
Iran snatch draw in World Cup opener, Spain stunned by Cape Verde
-
India eyes biofertilisers after Mideast war stoked supply fears
-
Iran begin fraught World Cup with 2-2 New Zealand draw
-
Uruguay's Bielsa says 'I'm not a model' after World Cup exchange
-
Most stocks rise, oil flat following peace deal-fuelled rally
-
Toxic 'time bomb' threatens Mekong river basin
-
UN chief to visit gang-plagued Haiti in solidarity with victims
-
Iraq coach urges outsiders to 'shock the world'
-
EU nears finish line on US tariff deal
-
With Zelensky present, G7 seeks to 'do something' on Ukraine
-
EU kicks off first phase of membership negotiations with Ukraine
-
Ukraine offers lucrative fixed-term army contracts to woo recruits
-
Netanyahu says will run in upcoming Israeli elections
-
Hundreds protest Iran's 'regime team' ahead of World Cup opener
-
US says Hormuz to be toll-free under Iran deal
-
Nearly half the world's children exposed to three or more climate risks: UNICEF
-
Tour of Switzerland set to showcase Pogacar's pre-Tour de France form
-
Iran prepare for tense World Cup opener, Spain stunned by Cape Verde
-
Uruguay frustrated by dogged Saudi Arabia in World Cup draw
-
Social networks, online video outweigh traditional media in 2026
-
Eight dead in fiery US bomber crash in California: military
-
Haaland primed for 'big impact' at World Cup, says Norway coach
-
Argentine fans challenge Kansas City's BBQ crown
-
Winds batter Shinnecock as US Open practice begins
-
'Competitive animal' Messi set for sixth World Cup
-
Spaun hopes grit and grinding brings US Open title repeat
-
Belgium fight back to draw with Egypt in World Cup group game
-
Fearsome France begin World Cup wary of over-confidence
-
Forget losing course: Fitzpatrick wants Shinnecock tough
-
No panic, says De la Fuente after Spain held by Cape Verde
-
Belgium and Egypt draw 1-1 in World Cup group game
-
Vilified Knicks owner Dolan gets some relief with NBA title
-
Clark seeks US Open redemption after smashing Oakmont locker
-
New York classical concerts adapt to growing population with dementia
-
Cape Verde hero Vozinha sheds 'tears of resilience' after stopping Spain
-
England ready to take final step at World Cup, says Saka
-
Trump says Hormuz to 'completely open' after US-Iran peace deal
-
Senegal aim to overcome 'regrettable' absence of fans denied World Cup visas
-
Spain held by tiny Cape Verde at World Cup as Iran make bow
-
US won't need 'much help' on Hormuz, Trump says at G7
-
Toothless Spain held by Cape Verde on World Cup debut
-
With visas denied, Senegal World Cup fans watch from afar
-
Crystal Palace appoint Sage as manager
-
Trump says Strait of Hormuz will be 'completely open' Friday
-
Brazil's Splitter to become new NBA Bulls coach: reports
-
Greed or player health? 'Damaging' World Cup drinks breaks under spotlight
-
Murdochs' Fox to acquire US streaming giant Roku
OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
BELLEVUE, WA / ACCESS Newswire / April 9, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or the "Company") today announced a strategic transaction for capital structure optimization with White Lion GBM Innovation Fund ("White Lion"), centered on the retirement of approximately $2.02 million of warrant overhang.
Elimination of $2.02 Million Warrant Overhang
As part of the transaction, OSR Holdings has retired approximately $2.02 million of outstanding warrants by consolidating them into a newly issued convertible promissory note.
The Company issued a $555,555 convertible note to secure near-term liquidity to support general corporate purposes and the continued execution of strategic priorities.
In connection with the warrant retirement, the extinguished warrants were effectively incorporated into the note, bringing the total face value of the instrument to $1,055,555.
This structure enables OSR Holdings to eliminate a substantial source of potential dilution at a significant discount to the prior overhang value, representing a highly efficient balance sheet optimization.
Premium Conversion Price at $1.00 per Share
The convertible note is structured with a fixed conversion price of $1.00 per share, representing approximately a 100% premium to the Company's most recent closing price of approximately $0.49 on April 8, 2026.
The premium conversion price reflects a shared alignment with long-term shareholder value and stands in contrast to conventional discounted convertible structures.
The $1.00 level is also strategically aligned with the Company's objective of maintaining compliance with NASDAQ minimum bid requirements.
Six-Month Conversion Restriction
The note was issued as a private placement without a registration statement:
Accordingly, the note includes a six-month restriction on conversion, ensuring that no shares may be issued into the public float during this period.
This feature further supports near-term trading stability by preventing immediate dilution following the transaction.
Management Commentary
"This transaction is fundamentally about removing structural overhang and strengthening our equity story," said Peter Hwang, CEO of OSR Holdings. "By retiring over $2 million in warrant overhang into a tightly structured instrument, we are meaningfully cleaning up our cap table. Furthermore, the $1.00 conversion price and six-month restriction demonstrate a shared commitment by our investor to stabilizing our valuation as we focus on regaining NASDAQ minimum bid compliance."
The Company believes this transaction represents a meaningful step in optimizing its capital structure, removing technical barriers to equity performance, and securing near-term capital to advance its strategic priorities across its immunotherapy, degenerative disease, and medtech platforms.
Further details regarding this transaction will be included in the Company's filings with the U.S. Securities and Exchange Commission.
About White Lion GBM Innovation Fund
The White Lion GBM Innovation Fund, one of Innovate GBM's core sponsors, focuses on strategic funding opportunities in glioblastoma drug development. The Innovation Fund leverages the ecosystem curated by Innovate GBM to gain insights from the GBM community-including neuro-oncologists, scientists, and patient advocacy groups-to guide capital allocation toward the most impactful opportunities.
About OSR Holdings, Inc.
OSR Holdings, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSRH engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.OSR-Holdings.com.
Investor Contact
OSR Holdings, Inc.
Investor Relations
[email protected]
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable U.S. securities laws, including statements regarding the Company's capital structure, liquidity, and expected benefits of the financing. These statements are subject to risks and uncertainties that could cause actual results to differ materially, including those described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements, except as required by law.
SOURCE: OSR Holdings, Inc.
View the original press release on ACCESS Newswire
L.Durand--AMWN